Company news: Pfizer and PhRMA

Pfizer and Shanghai Pharmaceutical Co. are partnering for a possible Pfizer product launch in China. The companies already co-promote pediatric flu vaccine Prevenar in China.

PhRMA announced its board leadership for the coming year. Sanofi-Aventis CEO Christopher Viehbacher will continue as board chairman of the trade group, while Lilly chief John Lechleiter becomes chairman-elect and Celgene CEO Robert Hugin board treasurer. Viehbacher stepped into the role last year when then-chairman Jeff Kindler abruptly left Pfizer.
You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.